Thus, accumulating evidence suggests that antigen-specific Tr1 cells develop either soon after or in parallel with corresponding effector CD4+ T cell populations as a mechanism to control the extent and magnitude of these latter CD4+ T cell responses during infection. The gene discussed is CD4; the disease is infection.